Lin Xichen Insider Trades

Insider Trading History

Track insider trading activity for Lin Xichen. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Structure Therapeutics
Structure Therapeutics GPCR
CHIEF SCIENTIFIC OFFICER
Holding Value $8.59M 228,960 shares
Last Trade
Mar 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.9M 97,071 shares
$50.46
$37.50
Structure Therapeutics
Structure Therapeutics GPCR
CHIEF SCIENTIFIC OFFICER
Holding Value $6.96M 185,592 shares
Last Trade
Mar 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.18M 18,735 shares
$63.04
$37.50
Structure Therapeutics
Structure Therapeutics GPCR
CHIEF SCIENTIFIC OFFICER
Holding Value $7.66M 204,327 shares
Last Trade
Jul 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$263k 12,846 shares
$20.51
$37.50
Structure Therapeutics
Structure Therapeutics GPCR
CHIEF SCIENTIFIC OFFICER
Holding Value $8.14M 217,173 shares
Last Trade
Jul 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.17M 57,078 shares
$20.51
$37.50
Structure Therapeutics
Structure Therapeutics GPCR
CHIEF SCIENTIFIC OFFICER
Holding Value $7.36M 196,386 shares
Last Trade
Mar 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.13M 196,386 shares
$21.05
$37.50
Structure Therapeutics
Structure Therapeutics GPCR
CHIEF SCIENTIFIC OFFICER
Holding Value $6M 160,095 shares
Last Trade
Mar 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$153k 6,441 shares
$23.75
$37.50
Structure Therapeutics
Structure Therapeutics GPCR
CHIEF SCIENTIFIC OFFICER
Holding Value $7.2M 191,907 shares
Last Trade
Jun 03, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.6M 106,200 shares
$52.74
$37.50
Structure Therapeutics
Structure Therapeutics GPCR
CHIEF SCIENTIFIC OFFICER
Holding Value $8.02M 213,800 shares
Last Trade
Jun 03, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.6M 106,200 shares
$52.74
$37.50
Structure Therapeutics
Structure Therapeutics GPCR
CHIEF SCIENTIFIC OFFICER
Holding Value $3.21M 85,707 shares
Last Trade
Jun 03, 2024 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$5.6M 106,200 shares
$52.74
$37.50
Structure Therapeutics
Structure Therapeutics GPCR
CHIEF SCIENTIFIC OFFICER
Holding Value $1.33M 35,400 shares
Last Trade
Jun 03, 2024 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$1.87M 35,400 shares
$52.74
$37.50
Structure Therapeutics
Structure Therapeutics GPCR
CHIEF SCIENTIFIC OFFICER
Holding Value $664k 17,700 shares
Last Trade
Jun 03, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$933k 17,700 shares
$52.74
$37.50
Structure Therapeutics
Structure Therapeutics GPCR
CHIEF SCIENTIFIC OFFICER
Holding Value $8.01M 213,486 shares
Last Trade
Mar 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.53M 213,486 shares
$35.25
$37.50
Structure Therapeutics
Structure Therapeutics GPCR
CHIEF SCIENTIFIC OFFICER
Holding Value $8.01M 213,486 shares
Last Trade
Mar 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.53M 213,486 shares
$35.25
$37.50

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up